New York State Common Retirement Fund’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Buy |
1,760,045
+7,121
| +0.4% | +$14.7K | ﹤0.01% | 1198 |
|
|
2025
Q1 | $3.86M | Buy |
1,752,924
+431,918
| +33% | +$950K | 0.01% | 1156 |
|
|
2024
Q4 | $2.02M | Buy |
1,321,006
+41,062
| +3% | +$62.8K | ﹤0.01% | 1414 |
|
|
2024
Q3 | $2.55M | Buy |
1,279,944
+35,021
| +3% | +$69.7K | ﹤0.01% | 1331 |
|
|
2024
Q2 | $4.36M | Buy |
1,244,923
+150,807
| +14% | +$528K | 0.01% | 1188 |
|
|
2024
Q1 | $3.03M | Sell |
1,094,116
-48
| -0% | -$133 | ﹤0.01% | 1307 |
|
|
2023
Q4 | $1.86M | Sell |
1,094,164
-277
| -0% | -$471 | ﹤0.01% | 1504 |
|
|
2023
Q3 | $1.13M | Sell |
1,094,441
-16,435
| -1% | -$16.9K | ﹤0.01% | 1687 |
|
|
2023
Q2 | $1.29M | Buy |
1,110,876
+39,752
| +4% | +$46.1K | ﹤0.01% | 1662 |
|
|
2023
Q1 | $1.62M | Sell |
1,071,124
-27,926
| -3% | -$42.2K | ﹤0.01% | 1638 |
|
|
2022
Q4 | $2.75M | Buy |
1,099,050
+160,698
| +17% | +$402K | ﹤0.01% | 1474 |
|
|
2022
Q3 | $3.96M | Buy |
938,352
+130,968
| +16% | +$553K | 0.01% | 1277 |
|
|
2022
Q2 | $2.25M | Sell |
807,384
-119
| -0% | -$332 | ﹤0.01% | 1592 |
|
|
2022
Q1 | $4.62M | Buy |
807,503
+4,935
| +0.6% | +$28.2K | ﹤0.01% | 1319 |
|
|
2021
Q4 | $7.33M | Buy |
802,568
+147,474
| +23% | +$1.35M | 0.01% | 1140 |
|
|
2021
Q3 | $7M | Buy |
655,094
+275,195
| +72% | +$2.94M | 0.01% | 1162 |
|
|
2021
Q2 | $5.9M | Buy |
379,899
+128,068
| +51% | +$1.99M | 0.01% | 1266 |
|
|
2021
Q1 | $4.08M | Buy |
251,831
+22,480
| +10% | +$364K | ﹤0.01% | 1374 |
|
|
2020
Q4 | $4.85M | Buy |
229,351
+20,423
| +10% | +$432K | 0.01% | 1271 |
|
|
2020
Q3 | $3.1M | Buy |
208,928
+19,700
| +10% | +$292K | ﹤0.01% | 1352 |
|
|
2020
Q2 | $2.78M | Buy |
189,228
+4,900
| +3% | +$72.1K | ﹤0.01% | 1399 |
|
|
2020
Q1 | $2.16M | Buy |
184,328
+7,894
| +4% | +$92.7K | ﹤0.01% | 1376 |
|
|
2019
Q4 | $4.15M | Buy |
176,434
+9,500
| +6% | +$223K | ﹤0.01% | 1320 |
|
|
2019
Q3 | $3.09M | Buy |
166,934
+2,258
| +1% | +$41.8K | ﹤0.01% | 1434 |
|
|
2019
Q2 | $3.06M | Buy |
164,676
+23,780
| +17% | +$442K | ﹤0.01% | 1451 |
|
|
2019
Q1 | $3.44M | Buy |
140,896
+12,393
| +10% | +$303K | ﹤0.01% | 1379 |
|
|
2018
Q4 | $3.33M | Buy |
128,503
+57,503
| +81% | +$1.49M | ﹤0.01% | 1346 |
|
|
2018
Q3 | $2.25M | Hold |
71,000
| – | – | ﹤0.01% | 1625 |
|
|
2018
Q2 | $2.76M | Buy |
71,000
+12,200
| +21% | +$474K | ﹤0.01% | 1514 |
|
|
2018
Q1 | $1.62M | Buy |
58,800
+10,200
| +21% | +$282K | ﹤0.01% | 1738 |
|
|
2017
Q4 | $880K | Hold |
48,600
| – | – | ﹤0.01% | 2106 |
|
|
2017
Q3 | $785K | Hold |
48,600
| – | – | ﹤0.01% | 2128 |
|
|
2017
Q2 | $673K | Buy |
48,600
+7,899
| +19% | +$109K | ﹤0.01% | 2263 |
|
|
2017
Q1 | $611K | Buy |
40,701
+5,701
| +16% | +$85.6K | ﹤0.01% | 2295 |
|
|
2016
Q4 | $459K | Hold |
35,000
| – | – | ﹤0.01% | 2405 |
|
|
2016
Q3 | $603K | Hold |
35,000
| – | – | ﹤0.01% | 2223 |
|
|
2016
Q2 | $632K | Buy |
35,000
+5,600
| +19% | +$101K | ﹤0.01% | 2179 |
|
|
2016
Q1 | $558K | Hold |
29,400
| – | – | ﹤0.01% | 2209 |
|
|
2015
Q4 | $785K | Buy |
29,400
+1,700
| +6% | +$45.4K | ﹤0.01% | 2099 |
|
|
2015
Q3 | $676K | Buy |
27,700
+2,970
| +12% | +$72.5K | ﹤0.01% | 2173 |
|
|
2015
Q2 | $771K | Buy |
+24,730
| New | +$771K | ﹤0.01% | 2324 |
|